These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15316023)

  • 1. Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice.
    Dai T; Abou-Rjaily GA; Al-Share' QY; Yang Y; Fernström MA; Deangelis AM; Lee AD; Sweetman L; Amato A; Pasquali M; Lopaschuk GD; Erickson SK; Najjar SM
    J Biol Chem; 2004 Oct; 279(43):45155-61. PubMed ID: 15316023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEACAM1 regulates insulin clearance in liver.
    Poy MN; Yang Y; Rezaei K; Fernström MA; Lee AD; Kido Y; Erickson SK; Najjar SM
    Nat Genet; 2002 Mar; 30(3):270-6. PubMed ID: 11850617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1.
    Park SY; Cho YR; Kim HJ; Hong EG; Higashimori T; Lee SJ; Goldberg IJ; Shulman GI; Najjar SM; Kim JK
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E517-24. PubMed ID: 16638824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism.
    DeAngelis AM; Heinrich G; Dai T; Bowman TA; Patel PR; Lee SJ; Hong EG; Jung DY; Assmann A; Kulkarni RN; Kim JK; Najjar SM
    Diabetes; 2008 Sep; 57(9):2296-303. PubMed ID: 18544705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.
    Abou-Rjaily GA; Lee SJ; May D; Al-Share QY; Deangelis AM; Ruch RJ; Neumaier M; Kalthoff H; Lin SH; Najjar SM
    J Clin Invest; 2004 Oct; 114(7):944-52. PubMed ID: 15467833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of insulin action by CEACAM1.
    Najjar SM
    Trends Endocrinol Metab; 2002 Aug; 13(6):240-5. PubMed ID: 12128284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.
    Huang S; Kaw M; Harris MT; Ebraheim N; McInerney MF; Najjar SM; Lecka-Czernik B
    Bone; 2010 Apr; 46(4):1138-45. PubMed ID: 20044046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.
    Russo L; Muturi HT; Ghadieh HE; Ghanem SS; Bowman TA; Noh HL; Dagdeviren S; Dogbey GY; Kim JK; Heinrich G; Najjar SM
    Diabetologia; 2017 Dec; 60(12):2463-2474. PubMed ID: 28913658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
    Al-Share QY; DeAngelis AM; Lester SG; Bowman TA; Ramakrishnan SK; Abdallah SL; Russo L; Patel PR; Kaw MK; Raphael CK; Kim AJ; Heinrich G; Lee AD; Kim JK; Kulkarni RN; Philbrick WM; Najjar SM
    Diabetes; 2015 Aug; 64(8):2780-90. PubMed ID: 25972571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin acutely decreases hepatic fatty acid synthase activity.
    Najjar SM; Yang Y; Fernström MA; Lee SJ; Deangelis AM; Rjaily GA; Al-Share QY; Dai T; Miller TA; Ratnam S; Ruch RJ; Smith S; Lin SH; Beauchemin N; Oyarce AM
    Cell Metab; 2005 Jul; 2(1):43-53. PubMed ID: 16054098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
    Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
    J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.
    Lee SJ; Heinrich G; Fedorova L; Al-Share QY; Ledford KJ; Fernstrom MA; McInerney MF; Erickson SK; Gatto-Weis C; Najjar SM
    Gastroenterology; 2008 Dec; 135(6):2084-95. PubMed ID: 18848945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1.
    Heinrich G; Russo L; Castaneda TR; Pfeiffer V; Ghadieh HE; Ghanem SS; Wu J; Faulkner LD; Ergün S; McInerney MF; Hill JW; Najjar SM
    J Biol Chem; 2016 May; 291(21):11124-32. PubMed ID: 27002145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.
    Moller DE; Chang PY; Yaspelkis BB; Flier JS; Wallberg-Henriksson H; Ivy JL
    Endocrinology; 1996 Jun; 137(6):2397-405. PubMed ID: 8641192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle.
    Richardson DK; Kashyap S; Bajaj M; Cusi K; Mandarino SJ; Finlayson J; DeFronzo RA; Jenkinson CP; Mandarino LJ
    J Biol Chem; 2005 Mar; 280(11):10290-7. PubMed ID: 15598661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangiferin Improved Palmitate-Induced-Insulin Resistance by Promoting Free Fatty Acid Metabolism in HepG2 and C2C12 Cells via PPAR
    Zhang Q; Kong X; Yuan H; Guan H; Li Y; Niu Y
    J Diabetes Res; 2019; 2019():2052675. PubMed ID: 30809553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance.
    Huan JN; Li J; Han Y; Chen K; Wu N; Zhao AZ
    J Biol Chem; 2003 Nov; 278(46):45638-50. PubMed ID: 12925533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity.
    Fournès B; Sadekova S; Turbide C; Létourneau S; Beauchemin N
    Oncogene; 2001 Jan; 20(2):219-30. PubMed ID: 11313949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.